JACC -- de Jongh et al. 40 (12): 2117 Figure IG1

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.

Figure 1 Flow-mediated dilation (FMD) (%) placebo versus simvastatin (familial hypercholesterolemia [FH]) at baseline and 28 weeks. Striped bar = baseline; white bar = 28 weeks. *p < 0.0001 vs. baseline; ${dagger}$ p < 0.05, ${Delta}$ FMD placebo vs. ${Delta}$ FMD simvastatin.